Target intelligence / Profile preview

Pathogen flavoenzyme (PFE)

Target
PFE
Molecular classification
Enzyme, Oxidoreductase, Flavoprotein
01

Overview

Pathogen flavoenzymes are a diverse class of proteins that utilize flavin adenine dinucleotide (FAD) or flavin mononucleotide (FMN) as essential cofactors to catalyze a wide range of redox reactions. These enzymes are critical for the survival, virulence, and metabolic adaptation of various bacteria, fungi, and protozoan parasites, often participating in the electron transport chain, DNA repair, and the maintenance of redox homeostasis. Because many pathogen flavoenzymes possess structural and mechanistic features distinct from their human counterparts, they are highly attractive targets for the development of selective antimicrobial and antiparasitic agents. Drugs targeting these enzymes typically function either by direct inhibition of the catalytic site, such as Plasmodium falciparum dihydroorotate dehydrogenase inhibitors for malaria, or by acting as prodrugs that are activated by the flavoenzyme into toxic intermediates, as seen with nitrofurans and nitroimidazoles. The therapeutic potential of this class is underscored by its involvement in essential pathways that, when disrupted, lead to pathogen death or increased susceptibility to host immune responses.

Other names
Flavin-dependent enzymeFlavoproteinFMN-dependent enzymeFAD-dependent enzymeMicrobial flavoenzyme
02

Mechanism of action

Inhibition of essential metabolic redox reactions or prodrug activation via enzymatic reduction to generate reactive cytotoxic species.

03

Biological functions

Redox signalingMetabolic pathway regulationElectron transport chainOxidative stress responseBiosynthesis of essential cofactorsDNA repair
04

Disease associations

InfectionTuberculosisMalariaTrypanosomiasisLeishmaniasisBacterial antibiotic resistance
05

Safety considerations

Cross-reactivity with human flavoenzymesOxidative stress in host cellsHemolytic anemia in G6PD-deficient patientsPotential for rapid development of resistance via enzyme mutations
06

Interacting drugs

Nitrofurantoin

5 more in the full profile.

07

Biomarkers

Flavin adenine dinucleotide (FAD) levelsFlavin mononucleotide (FMN) levelsEnzymatic activity assaysPathogen load reduction

Beyond the preview

Go deeper on Pathogen flavoenzyme (PFE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogen flavoenzyme (PFE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call